Dr. Jason M. Bierenbaum
Overview
Jason Bierenbaum, MD, is a medical oncologist and hematologist at UPMC Hillman Cancer Center. Dr. Bierenbaum specializes in lung cancer, gastrointestinal cancers, and myelodysplasia.
Dr. Bierenbaum is rated as an Advanced provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Pleuropulmonary Blastoma, and Childhood Iron Deficiency Anemia.
His clinical research consists of co-authoring 5 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- PPO
- HMO
- MANAGED MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
1500 5th Avenue, Mckeesport, PA 15132
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
UPMC Hillman Cancer Center
Alison Sehgal, MD, is an assistant professor of medicine at the University of Pittsburgh School of Medicine, and a hematologist/medical oncologist specializing in allogeneic and autologous stem cell transplant, lymphoma, leukemia, and multiple myeloma. Dr. Sehgal is conducting research in stem cell transplant and drug development in hematologic malignancies. Dr. Sehgal is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Kathleen Dorritie, MD, is a hematologist/medical oncologist at UPMC Hillman Cancer Center specializing in hematologic malignancies and stem cell transplantation. Her research focuses on early phase clinical trials for lymphoid malignancies. She has been very involved in the development of the CAR T-cell program at UPMC and has also worked to develop a stem cell transplant program for hemoglobinopathies, including sickle cell disease. Dr. Dorritie is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. Her top areas of expertise are Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), B-Cell Lymphoma, Bone Marrow Aspiration, and Bone Marrow Transplant.
UPMC Hillman Cancer Center
Stanley Marks, MD, specializes in hematology oncology and medical oncology and is board-certified in hematology and internal medicine by the American Board of Internal medicine. Dr. Marks completed his medical degree at the University of Pittsburgh School of Medicine. He completed his residency training at Presbyterian Hospital, and fellowship training in clinical medicine and research medicine at Peter Bent Brigham Hospital, Harvard Medical School and Dana Farber Cancer Center. He has received numerous awards including the Golden Apple Award for Outstanding Dedication to Housestaff Education from Allegheny General Hospital, Hillel Academy Outstanding Alumnus, and The Winged Victory of Samothrace Award from the Leukemia, Lymphoma Society of Western Pennsylvania. Dr. Marks is rated as a Distinguished provider by MediFind in the treatment of Non-Hodgkin Lymphoma. His top areas of expertise are Non-Hodgkin Lymphoma, Primary Lymphoma of the Brain, Gastric Lymphoma, and Follicular Lymphoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerDr. Bierenbaum isDistinguished. Learn about Lung Cancer.
- Pleuropulmonary BlastomaDr. Bierenbaum isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Bierenbaum isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Advanced
- ALK-Positive Non-Small Cell Lung CancerDr. Bierenbaum isAdvanced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- AnemiaDr. Bierenbaum isAdvanced. Learn about Anemia.
- Childhood Iron Deficiency AnemiaDr. Bierenbaum isAdvanced. Learn about Childhood Iron Deficiency Anemia.
- EGFR Positive Lung CancerDr. Bierenbaum isAdvanced. Learn about EGFR Positive Lung Cancer.
- Essential ThrombocythemiaDr. Bierenbaum isAdvanced. Learn about Essential Thrombocythemia.
- Familial Prostate CancerDr. Bierenbaum isAdvanced. Learn about Familial Prostate Cancer.
- Experienced
- Acute Myeloid Leukemia (AML)Dr. Bierenbaum isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Bierenbaum isExperienced. Learn about Agranulocytosis.
- AngiosarcomaDr. Bierenbaum isExperienced. Learn about Angiosarcoma.
- B-Cell LymphomaDr. Bierenbaum isExperienced. Learn about B-Cell Lymphoma.
- Breast CancerDr. Bierenbaum isExperienced. Learn about Breast Cancer.
- Childhood Acute Myeloid LeukemiaDr. Bierenbaum isExperienced. Learn about Childhood Acute Myeloid Leukemia.